New Chinese Medical Device Standards Released in March 2026

Date

March 18, 2026

Category

Other Regulations

Description

The National Medical Products Administration (NMPA) has introduced important updates to China’s medical device regulatory standards. In March 2026, the authority approved and released 26 new and revised industry standards covering a wide range of medical device categories and supporting related areas, including:

• Orthopedic implants (e.g., metal bone plates, bone screws)
• Joint replacement systems (hip and knee prostheses)
• Diagnostic and imaging technologies (X‑ray components, mobile CT systems)
• Dental devices
• Implantable and cardiovascular devices
• Ultrasound physiotherapy equipment
• Traditional Chinese Medicine (TCM) devices
• IVD-related requirements, including clinical trial processes and sample management
• Real‑world data terminology for medical devices
• Additive manufacturing materials, such as PEEK powder
• Medical device software compliance guidance

Source: 国家药监局关于发布《骨接合植入器械金属接骨板》等26项医疗器械行业标准的公告（2026年第24号）

The newly published standards will take effect between 1 March 2027 and 1 March 2029, depending on the individual standard.

What this means for manufacturers:

Given the breadth of updates, organizations with products marketed in China - or planning entry into the Chinese market - should begin:

• Reviewing the full text of the newly issued standards
• Assessing the impact on existing product design, testing, and technical documentation
• Updating quality management and regulatory compliance processes where necessary
• Preparing timelines for implementation to ensure alignment with the upcoming enforcement dates

Early evaluation will help manufacturers secure a smooth transition and maintain uninterrupted compliance with the evolving Chinese regulatory landscape.